|
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
| 226.98 USD | -0.50% |
|
-1.31% | -5.65% |
| 15/04 | Baird Adjusts Price Target on ResMed to $254 From $272, Maintains Neutral Rating | MT |
| 13/04 | Mizuho Adjusts Price Target on ResMed to $255 From $300, Maintains Outperform Rating | MT |
- Stock Market
- Equities
- RMD Stock
- Charts ResMed, Inc.
- Static Chart
Select your edition
All financial news and data tailored to specific country editions
MarketScreener is also available in this country: United States.
Switch edition
Stay in the current country edition